Paper on vaccine development 🔬

9 May 2022

A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell mediated immunity

A nice illustration of the strong ecosystem in Flanders-Belgium for vaccine development: a collaboration between Ziphius (a young biotech company), University of Ghent (Faculty of Veterinary Medicine - Ghent University and Cancer Research Institute Ghent (CRIG)), University of Leuven (Rega Institute for Medical Research), Institute of Tropical Medicine Antwerp and University of Antwerp.

This paper is now published in Molecular Therapy.